DURECT Corporation names new chief financial officer.

M2 EQUITYBITES-July 6, 2022-DURECT Corporation names new chief financial officer

(C)2022 M2 COMMUNICATIONS http://www.m2.com

DURECT Corporation (Nasdaq: DRRX), a US-based biopharmaceutical company, announced on Tuesday that it has named Timothy M Papp as its new chief financial officer.

In the new role, Papp will direct and manage all financial and capital markets activities including accounting, financial reporting, financial planning and analysis, financial strategy, and investor relations.

Papp has more than 25 years of corporate finance experience, including 15 years in the Biopharma sector. He has served as...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT